Mike Polark
Stock Analyst at Wolfe Research
(3.30)
# 1,035
Out of 4,734 analysts
76
Total ratings
47.73%
Success rate
4.05%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Downgrades: Underperform | $60 | $69.78 | -14.02% | 4 | Jan 16, 2025 | |
| NVRO Nevro | Maintains: Neutral | $5 → $6 | $4.57 | +31.29% | 10 | Nov 12, 2024 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $240 → $252 | $177.68 | +41.83% | 5 | Nov 5, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $100 → $79 | $108.33 | -27.07% | 7 | Nov 1, 2024 | |
| RMD ResMed | Downgrades: Underperform | $180 | $239.78 | -24.93% | 5 | Sep 18, 2024 | |
| ZBH Zimmer Biomet Holdings | Initiates: Peer Perform | n/a | $109.56 | - | 1 | Sep 10, 2024 | |
| SYK Stryker | Initiates: Outperform | $405 | $383.42 | +5.63% | 1 | Sep 10, 2024 | |
| LIVN LivaNova | Maintains: Neutral | $55 | $48.30 | +13.87% | 8 | Aug 28, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $487 → $503 | $592.64 | -15.13% | 7 | Jul 19, 2024 | |
| PODD Insulet | Upgrades: Outperform | $200 | $275.81 | -27.49% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $113.48 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $181.27 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $84.38 | +43.40% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $35.15 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $12.98 | +92.60% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $172.29 | -4.23% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $98.66 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | n/a | $88.08 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $11.97 | +8.60% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $10.91 | +92.48% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $209.62 | +19.26% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $2.14 | +1,909.35% | 1 | Sep 2, 2020 |
Edwards Lifesciences
Jan 16, 2025
Downgrades: Underperform
Price Target: $60
Current: $69.78
Upside: -14.02%
Nevro
Nov 12, 2024
Maintains: Neutral
Price Target: $5 → $6
Current: $4.57
Upside: +31.29%
Inspire Medical Systems
Nov 5, 2024
Maintains: Outperform
Price Target: $240 → $252
Current: $177.68
Upside: +41.83%
iRhythm Technologies
Nov 1, 2024
Maintains: Outperform
Price Target: $100 → $79
Current: $108.33
Upside: -27.07%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $239.78
Upside: -24.93%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $109.56
Upside: -
Stryker
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $383.42
Upside: +5.63%
LivaNova
Aug 28, 2024
Maintains: Neutral
Price Target: $55
Current: $48.30
Upside: +13.87%
Intuitive Surgical
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $592.64
Upside: -15.13%
Insulet
May 7, 2024
Upgrades: Outperform
Price Target: $200
Current: $275.81
Upside: -27.49%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $113.48
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $181.27
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $84.38
Upside: +43.40%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $35.15
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $12.98
Upside: +92.60%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $172.29
Upside: -4.23%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $98.66
Upside: -
Jul 6, 2022
Initiates: Underperform
Price Target: n/a
Current: $88.08
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $11.97
Upside: +8.60%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $10.91
Upside: +92.48%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $209.62
Upside: +19.26%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $2.14
Upside: +1,909.35%